Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and eptifibatide

cetylpyridinium chloride anhydrous has been researched along with eptifibatide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, TF; Deng, CY; Huang, XZ; Kuang, SJ; Li, XH; Lin, QX; Lin, SG; Mai, LP; Shan, ZX; Yang, M; Yu, XY; Zhou, ZL; Zhu, P1

Trials

1 trial(s) available for cetylpyridinium chloride anhydrous and eptifibatide

ArticleYear
Improved liquid chromatography-tandem mass spectrometry method for the analysis of eptifibatide in human plasma.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2010, Aug-01, Volume: 878, Issue:23

    Topics: Asian People; Chromatography, Liquid; Drug Stability; Eptifibatide; Female; Health; Humans; Male; Peptides; Platelet Aggregation Inhibitors; Reference Standards; Reproducibility of Results; Tandem Mass Spectrometry; Time Factors

2010